Suppr超能文献

研究小分子激活和抑制炎症小体的技术。

Techniques to Study Inflammasome Activation and Inhibition by Small Molecules.

机构信息

Línea de Inflamación Molecular, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Hospital Clínico Universitario Virgen de la Arrixaca, 30120 Murcia, Spain.

出版信息

Molecules. 2021 Mar 18;26(6):1704. doi: 10.3390/molecules26061704.

Abstract

Inflammasomes are immune cytosolic oligomers involved in the initiation and progression of multiple pathologies and diseases. The tight regulation of these immune sensors is necessary to control an optimal inflammatory response and recover organism homeostasis. Prolonged activation of inflammasomes result in the development of chronic inflammatory diseases, and the use of small drug-like inhibitory molecules are emerging as promising anti-inflammatory therapies. Different aspects have to be taken in consideration when designing inflammasome inhibitors. This review summarizes the different techniques that can be used to study the mechanism of action of potential inflammasome inhibitory molecules.

摘要

炎症小体是一种免疫细胞溶质寡聚体,参与多种病理和疾病的发生和发展。这些免疫传感器的紧密调节对于控制最佳炎症反应和恢复机体平衡是必要的。炎症小体的长期激活导致慢性炎症性疾病的发展,而使用小分子类抑制分子作为有前途的抗炎治疗方法正在出现。在设计炎症小体抑制剂时需要考虑多个方面。本综述总结了可用于研究潜在炎症小体抑制分子作用机制的不同技术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b740/8003184/462eb12feb3b/molecules-26-01704-g001.jpg

相似文献

1
Techniques to Study Inflammasome Activation and Inhibition by Small Molecules.
Molecules. 2021 Mar 18;26(6):1704. doi: 10.3390/molecules26061704.
2
Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases.
Arch Pharm Res. 2021 Jan;44(1):16-35. doi: 10.1007/s12272-021-01307-9. Epub 2021 Feb 3.
3
The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases.
Adv Immunol. 2020;145:55-93. doi: 10.1016/bs.ai.2019.11.003. Epub 2019 Dec 9.
4
Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases.
Eur J Med Chem. 2020 Jan 1;185:111822. doi: 10.1016/j.ejmech.2019.111822. Epub 2019 Oct 30.
5
Exogenous nanoparticles and endogenous crystalline molecules as danger signals for the NLRP3 inflammasomes.
J Cell Physiol. 2019 May;234(5):5436-5450. doi: 10.1002/jcp.27475. Epub 2018 Oct 28.
6
The NLRP3 Inflammasome and Its Role in the Pathogenicity of Leukemia.
Int J Mol Sci. 2021 Jan 28;22(3):1271. doi: 10.3390/ijms22031271.
7
Cellular Models and Assays to Study NLRP3 Inflammasome Biology.
Int J Mol Sci. 2020 Jun 16;21(12):4294. doi: 10.3390/ijms21124294.
8
Emerging Activators and Regulators of Inflammasomes and Pyroptosis.
Trends Immunol. 2019 Nov;40(11):1035-1052. doi: 10.1016/j.it.2019.09.005. Epub 2019 Oct 29.
9
Non-coding RNAs: The key regulators in NLRP3 inflammasome-mediated inflammatory diseases.
Int Immunopharmacol. 2021 Nov;100:108105. doi: 10.1016/j.intimp.2021.108105. Epub 2021 Sep 1.
10
NLRP3 inflammasome in ischemic stroke: As possible therapeutic target.
Int J Stroke. 2019 Aug;14(6):574-591. doi: 10.1177/1747493019841242. Epub 2019 Apr 2.

引用本文的文献

1
Phytochemical Composition Antioxidant and Anti-Inflammatory Activity of and .
Antioxidants (Basel). 2024 Aug 20;13(8):1016. doi: 10.3390/antiox13081016.
2
The Inflammasome Adaptor Protein ASC in Plasma as a Biomarker of Early Cognitive Changes.
Int J Mol Sci. 2024 Jul 16;25(14):7758. doi: 10.3390/ijms25147758.
3
Silica exposure activates non-canonical inflammasome complex in intratracheal instilled rat model.
Toxicol Res (Camb). 2022 Aug 27;11(5):784-790. doi: 10.1093/toxres/tfac061. eCollection 2022 Oct.
4
Emerging chemistry and biology in protein glutathionylation.
Curr Opin Chem Biol. 2022 Dec;71:102221. doi: 10.1016/j.cbpa.2022.102221. Epub 2022 Oct 9.
5
spores induce autophagy and downregulate inflammatory mediators in human peripheral blood-derived macrophages.
Curr Res Microb Sci. 2022 Jun 18;3:100145. doi: 10.1016/j.crmicr.2022.100145. eCollection 2022.
6
Lipid-protein interactions regulating the canonical and the non-canonical NLRP3 inflammasome.
Prog Lipid Res. 2022 Jul;87:101182. doi: 10.1016/j.plipres.2022.101182. Epub 2022 Jul 25.
7
Glial Cells and Brain Diseases: Inflammasomes as Relevant Pathological Entities.
Front Cell Neurosci. 2022 Jun 16;16:929529. doi: 10.3389/fncel.2022.929529. eCollection 2022.
8
Association of pyroptosis and severeness of COVID-19 as revealed by integrated single-cell transcriptome data analysis.
Immunoinformatics (Amst). 2022 Jun;6:100013. doi: 10.1016/j.immuno.2022.100013. Epub 2022 Apr 10.
9
orter: A Novel Inducible Human CASP1/NALP3/ASC Inflammasome Biosensor.
J Inflamm Res. 2022 Feb 19;15:1183-1194. doi: 10.2147/JIR.S333725. eCollection 2022.
10
Molecular and Cellular Mechanisms Influenced by Postbiotics.
Int J Mol Sci. 2021 Dec 15;22(24):13475. doi: 10.3390/ijms222413475.

本文引用的文献

1
NINJ1 mediates plasma membrane rupture during lytic cell death.
Nature. 2021 Mar;591(7848):131-136. doi: 10.1038/s41586-021-03218-7. Epub 2021 Jan 20.
2
ATP-Binding and Hydrolysis in Inflammasome Activation.
Molecules. 2020 Oct 7;25(19):4572. doi: 10.3390/molecules25194572.
3
Zebrafish as a model for inflammation and drug discovery.
Drug Discov Today. 2020 Dec;25(12):2201-2211. doi: 10.1016/j.drudis.2020.09.036. Epub 2020 Oct 6.
4
Inflammasome Assays In Vitro and in Mouse Models.
Curr Protoc Immunol. 2020 Dec;131(1):e107. doi: 10.1002/cpim.107.
5
Succination inactivates gasdermin D and blocks pyroptosis.
Science. 2020 Sep 25;369(6511):1633-1637. doi: 10.1126/science.abb9818. Epub 2020 Aug 20.
6
Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis.
J Hepatol. 2021 Jan;74(1):156-167. doi: 10.1016/j.jhep.2020.07.041. Epub 2020 Aug 4.
7
The NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis.
Semin Liver Dis. 2020 Aug;40(3):298-306. doi: 10.1055/s-0040-1708540. Epub 2020 Jun 11.
8
FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation.
Nat Immunol. 2020 Jul;21(7):736-745. doi: 10.1038/s41590-020-0669-6. Epub 2020 May 4.
10
NLRP3 inflammasome activation drives tau pathology.
Nature. 2019 Nov;575(7784):669-673. doi: 10.1038/s41586-019-1769-z. Epub 2019 Nov 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验